HDAC9 and gastric cancer: Both miR-383-5p (HR=2.49, 95% CI=1.13−6.79, P=0.027) and HDAC9 (HR=2.82, 95% CI=1.26−7.53, P=0.019) were identified as independent prognostic factors for predicting overall survival in GC patients (Table 3).